Insider Transactions in Q1 2022 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2022
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
7,579
-2.45%
|
$75,790
$10.95 P/Share
|
|
Feb 16
2022
|
John Northcott SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,852
-2.09%
|
$48,520
$10.95 P/Share
|
|
Feb 16
2022
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
12,480
-2.07%
|
$124,800
$10.95 P/Share
|
|
Feb 16
2022
|
Jillian B. Thomsen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,363
-1.41%
|
$23,630
$10.95 P/Share
|
|
Feb 16
2022
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,661
-2.94%
|
$36,610
$10.95 P/Share
|
|
Feb 16
2022
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
10,912
-3.83%
|
$109,120
$10.95 P/Share
|